Skip to main content
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1989 Jan;46(1):56–59. doi: 10.1136/oem.46.1.56

In vitro effect of toluene diisocyanate on beta adrenergic and muscarinic receptor function in lung tissue of the rat.

P J Borm 1, A Bast 1, O P Zuiderveld 1
PMCID: PMC1009724  PMID: 2537651

Abstract

To investigate the role of pharmacological mechanisms in toluene diisocyanate (TDI) induced occupational asthma, the effects of TDI on rat trachea ring and lung parenchymal strip were studied in vitro. The most prominent effect observed was a stimulation of metacholine (1 microM) induced contraction of the tracheal ring by 1 microM TDI (added in dimethy sulphoxide). The results were less pronounced when TDI was added from a stock solution prepared in water, which is possibly due to (co)polymerisation. It is concluded that the pharmacological effect of TDI may result from an autonomic imbalance between cholinergic and beta-adrenergic neural control.

Full text

PDF
56

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes P. J. Neural control of human airways in health and disease. Am Rev Respir Dis. 1986 Dec;134(6):1289–1314. doi: 10.1164/arrd.1986.134.5.1289. [DOI] [PubMed] [Google Scholar]
  2. Bernstein I. L. Isocyanate-induced pulmonary diseases: a current perspective. J Allergy Clin Immunol. 1982 Jul;70(1):24–31. doi: 10.1016/0091-6749(82)90197-x. [DOI] [PubMed] [Google Scholar]
  3. Brown W. E., Green A. H., Karol M. H., Alarie Y. C. Inhibition of cholinesterase activity by isocyanates. Toxicol Appl Pharmacol. 1982 Mar 30;63(1):45–52. doi: 10.1016/0041-008x(82)90025-4. [DOI] [PubMed] [Google Scholar]
  4. Butcher B. T., Karr R. M., O'Neil C. E., Wilson M. R., Dharmarajan V., Salvaggio J. E., Weill H. Inhalation challenge and pharmacologic studies of toluene diisocyanate (TDI)-sensitive workers. J Allergy Clin Immunol. 1979 Aug;64(2):146–152. doi: 10.1016/0091-6749(79)90049-6. [DOI] [PubMed] [Google Scholar]
  5. Butcher B. T., Salvaggio J. E., O'Neil C. E., Weill H., Garg O. Toluene diisocyanate pulmonary disease: immunopharmacologic and mecholyl challenge studies. J Allergy Clin Immunol. 1977 Mar;59(3):223–227. doi: 10.1016/0091-6749(77)90153-1. [DOI] [PubMed] [Google Scholar]
  6. Butcher B. T., Salvaggio J. E., Weill H., Ziskind M. M. Toluene diisocyanate (TDI) pulmonary disease: immunologic and inhalation challenge studies. J Allergy Clin Immunol. 1976 Jul;58(1 Pt 1):89–100. doi: 10.1016/0091-6749(76)90110-x. [DOI] [PubMed] [Google Scholar]
  7. Cockcroft D. W., Mink J. T. Isocyanate-induced asthma in an automobile spray painter. Can Med Assoc J. 1979 Sep 8;121(5):602–604. [PMC free article] [PubMed] [Google Scholar]
  8. Dewair M., Baur X., Mauermayer R. Inhibition of acetylcholinesterase by diisocyanates and its spontaneous reactivation. Int Arch Occup Environ Health. 1983;52(3):257–261. doi: 10.1007/BF00526524. [DOI] [PubMed] [Google Scholar]
  9. Kenakin T. P. The quantification of relative efficacy of agonists. J Pharmacol Methods. 1985 Jul;13(4):281–308. doi: 10.1016/0160-5402(85)90011-7. [DOI] [PubMed] [Google Scholar]
  10. Kramer K., Doelman C. J., Timmerman H., Bast A. A disbalance between beta-adrenergic and muscarinic responses caused by hydrogen peroxide in rat airways in vitro. Biochem Biophys Res Commun. 1987 May 29;145(1):357–362. doi: 10.1016/0006-291x(87)91329-5. [DOI] [PubMed] [Google Scholar]
  11. Mapp C. E., Di Giacomo G. R., Omini C., Broseghini C., Fabbri L. M. Late, but not early, asthmatic reactions induced by toluene-diisocyanate are associated with increased airway responsiveness to methacholine. Eur J Respir Dis. 1986 Oct;69(4):276–284. [PubMed] [Google Scholar]
  12. McKay R. T., Brooks S. M. Effect of toluene diisocyanate on beta adrenergic receptor function. Biochemical and physiologic studies. Am Rev Respir Dis. 1983 Jul;128(1):50–53. doi: 10.1164/arrd.1983.128.1.50. [DOI] [PubMed] [Google Scholar]
  13. O'Brien I. M., Newman-Taylor A. J., Burge P. S., Harries M. G., Fawcett I. W., Pepys J. Toluene di-isocyanate-induced asthma. II. Inhalation challenge tests and bronchial reactivity studies. Clin Allergy. 1979 Jan;9(1):7–15. doi: 10.1111/j.1365-2222.1979.tb01517.x. [DOI] [PubMed] [Google Scholar]
  14. Vanert M., Battigelli M. C. Mechanism of respiratory injury by TDI (toluene disocyanate). Ann Allergy. 1975 Sep;35(3):142–147. [PubMed] [Google Scholar]
  15. Venables K. M. Epidemiology and the prevention of occupational asthma. Br J Ind Med. 1987 Feb;44(2):73–75. doi: 10.1136/oem.44.2.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. White W. G., Morris M. J., Sugden E., Zapata E. Isocyanate-induced asthma in a car factory. Lancet. 1980 Apr 5;1(8171):756–760. doi: 10.1016/s0140-6736(80)91247-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES